Compounds > bms204352
Page last updated: 2024-09-05

bms204352 and chloramphenicol

bms204352 has been researched along with chloramphenicol in 4 studies

Compound Research Comparison

Studies
(bms204352)		Trials
(bms204352)		Recent Studies (post-2010)
(bms204352)		Studies
(chloramphenicol)		Trials
(chloramphenicol)		Recent Studies (post-2010) (chloramphenicol)
4911220,1133881,464

Protein Interaction Comparison

ProteinTaxonomybms204352 (IC50)chloramphenicol (IC50)
30S ribosomal protein S6Escherichia coli K-120.43
30S ribosomal protein S7Escherichia coli K-120.43
50S ribosomal protein L15Escherichia coli K-120.43
50S ribosomal protein L10Escherichia coli K-120.43
50S ribosomal protein L11Escherichia coli K-120.43
50S ribosomal protein L7/L12Escherichia coli K-120.43
50S ribosomal protein L19Escherichia coli K-120.43
50S ribosomal protein L1Escherichia coli K-120.43
50S ribosomal protein L20Escherichia coli K-120.43
50S ribosomal protein L27Escherichia coli K-120.43
50S ribosomal protein L28Escherichia coli K-120.43
50S ribosomal protein L29Escherichia coli K-120.43
50S ribosomal protein L31Escherichia coli K-120.43
50S ribosomal protein L31 type BEscherichia coli K-120.43
50S ribosomal protein L32Escherichia coli K-120.43
50S ribosomal protein L33Escherichia coli K-120.43
50S ribosomal protein L34Escherichia coli K-120.43
50S ribosomal protein L35Escherichia coli K-120.43
50S ribosomal protein L36Escherichia coli K-120.43
30S ribosomal protein S10Escherichia coli K-120.43
30S ribosomal protein S11Escherichia coli K-120.43
30S ribosomal protein S12Escherichia coli K-120.43
30S ribosomal protein S13Escherichia coli K-120.43
30S ribosomal protein S16Escherichia coli K-120.43
30S ribosomal protein S18Escherichia coli K-120.43
30S ribosomal protein S19Escherichia coli K-120.43
30S ribosomal protein S20Escherichia coli K-120.43
30S ribosomal protein S2Escherichia coli K-120.43
30S ribosomal protein S3Escherichia coli K-120.43
30S ribosomal protein S4Escherichia coli K-120.43
30S ribosomal protein S5Escherichia coli K-120.43
30S ribosomal protein S8Escherichia coli K-120.43
30S ribosomal protein S9Escherichia coli K-120.43
50S ribosomal protein L13Escherichia coli K-120.43
50S ribosomal protein L14Escherichia coli K-120.43
50S ribosomal protein L16Escherichia coli K-120.43
50S ribosomal protein L23Escherichia coli K-120.43
30S ribosomal protein S15Escherichia coli K-120.43
50S ribosomal protein L17Escherichia coli K-120.43
50S ribosomal protein L21Escherichia coli K-120.43
50S ribosomal protein L30Escherichia coli K-120.43
50S ribosomal protein L6Escherichia coli K-120.43
30S ribosomal protein S14Escherichia coli K-120.43
30S ribosomal protein S17Escherichia coli K-120.43
30S ribosomal protein S1Escherichia coli K-120.43
50S ribosomal protein L18Escherichia coli K-120.43
50S ribosomal protein L2Escherichia coli K-120.43
50S ribosomal protein L3Escherichia coli K-120.43
50S ribosomal protein L24Escherichia coli K-120.43
50S ribosomal protein L4Escherichia coli K-120.43
50S ribosomal protein L22Escherichia coli K-120.43
50S ribosomal protein L5Escherichia coli K-120.43
30S ribosomal protein S21Escherichia coli K-120.43
50S ribosomal protein L25Escherichia coli K-120.43
50S ribosomal protein L36 2Escherichia coli K-120.43

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, TK; Ensom, MH; Kiang, TK1
Lombardo, F; Obach, RS; Waters, NJ1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Reviews

1 review(s) available for bms204352 and chloramphenicol

ArticleYear
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005

Other Studies

3 other study(ies) available for bms204352 and chloramphenicol

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013